The Medicine & Healthcare products Regulatory Agency (MHRA) has approved the first licensed low-dose atropine (LDA) treatment for slowing the progression of childhood myopia.

We are concerned that primary eye care has been omitted as a priority opportunity in the framework.

The College of Optometrists has responded to General Optical Council (GOC) consultation on draft guidance on the care of patients in vulnerable circumstances and maintaining appropriate sexual boundaries.